HAE

美国血液技术
NYSE

实时行情|Nasdaq Last Sale

84.09
-0.06
-0.07%
交易中 12:40 08/14 EDT
开盘
83.95
昨收
84.15
最高
84.88
最低
83.11
成交量
20.45万
成交额
--
52周最高
140.36
52周最低
63.41
市值
42.63亿
市盈率(TTM)
45.50
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测HAE价格均价为113.67,最高价位145.00,最低价为93.00。

EPS

HAE 新闻

更多
Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced it will present results of its IMPACT (IMproving PlasmA CollecTion) study at the 20
PR Newswire · 08/07 10:45
Haemonetics (HAE) Q1 Earnings Beat Estimates, Margins Down
Haemonetics' (HAE) first-quarter fiscal 2021 results reflect impressive performance by Blood Center segment despite dismal overall performance during the coronavirus-led crisis.
Zacks · 08/05 13:52
Raymond James Maintains Outperform on Haemonetics, Lowers Price Target to $93
Raymond James maintains Haemonetics (NYSE:HAE) with a Outperform and lowers the price target from $113 to $93.
Benzinga · 08/05 11:29
Raymond James Maintains Outperform on Haemonetics, Lowers Price Target to $93
Raymond James maintains Haemonetics (NYSE:HAE) with a Outperform and lowers the price target from $113 to $93.
Benzinga · 08/05 11:29
Haemonetics EPS beats by $0.05, misses on revenue
Haemonetics (NYSE:HAE): Q1 Non-GAAP EPS of $0.46 beats by $0.05; GAAP EPS of $0.21 beats by $0.09. Revenue of $195.58M (-18.0% Y/Y) misses by $2.69M. Press
seekingalpha · 08/04 15:04
Haemonetics (HAE) Surpasses Q1 Earnings and Revenue Estimates
Haemonetics (HAE) delivered earnings and revenue surprises of 12.20% and 1.35%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 11:30
Haemonetics Q1 Adj. EPS $0.46 Beats $0.41 Estimate, Sales $196.00M Miss $198.27M Estimate
Haemonetics (NYSE:HAE) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.41 by 12.2 percent. This is a 43.21 percent decrease over earnings of $0.81 per share from the same
Benzinga · 08/04 10:14
Haemonetics First Quarter Fiscal 2021 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter fiscal 2021, which ended June 27, 2020, are available on its Investor Relations website.
PR Newswire · 08/04 10:00

所属板块

医疗设备、用品及经销
-0.96%
医疗设备和用品
-1.04%

热门股票

代码
价格
涨跌幅

HAE 简况

Haemonetics Corporation(Haemonetics)是一家医疗保健公司。该公司为从事血液加工、处理和分析业务的客户提供各种产品。该公司的业务部门包括日本部门,欧洲、中东和非洲(EMEA)部门,北美血浆部门和所有其他部门。血浆分离器通过Haemonetics提供的血浆收集系统和软件制造药物。该公司向收集血浆的客户提供血浆收集和存储产品,包括“PCS”品牌的血浆收集设备和一次性用品、血浆收集容器和生理盐水等静脉注射溶液。Haemonetics为血液收集中心提供自动血液成分和手动全血收集系统,以收集血液制品。该公司提供一系列血液管理解决方案。该公司有一套集成软件解决方案,包括献血计划和血液采集解决方案。
展开

微牛提供Haemonetics Corporation(NYSE-HAE)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的HAE股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易HAE股票基本功能。